Koninklijke DSM NV: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)
Koninklijke DSM NV Completes Fortitech Inc Acquisition
Koninklijke DSM NV announced that it has completed the acquisition of Fortitech Inc (Fortitech). The transaction, for a total enterprise value of USD 634 million (about EUR 495 million) strengthens the Human Nutrition and Health business, by expanding the Company’s value chain presence and adding additional capabilities. As a result of the acquisition, announced on November 8, 2012, approximately 520 employees are joining the Company.
Latest Developments for Koninklijke DSM NV
- Koninklijke DSM NV and JLL Create Pharma Services Company In USD2.6 Billion Transaction; Global CDMO Company Combines DSM Pharmaceutical Products And Patheon Inc
- Koninklijke DSM NV Updates Its FY 2013 EBITDA Guidance Above Analysts' Estimates
- Koninklijke DSM NV Updates Its FY 2013-2015 EBITDA Guidance Below Analysts' Estimates
- Koninklijke DSM NV Confirms FY 2013 EBITDA Guidance
Latest Key Developments in Chemicals
- Share this
- Digg this